15 reports

Abstract: - Global Acute Coronary Syndrome Market to Reach $67.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Coronary Syndrome estimated at US$30.3 Billion in the year 2020, is projected to reach a revised size of US$67.7 Billion by 2027, growing at a CAGR of 12.2% over the period 2020-2027....

  • Acute Coronary Syndrome
  • World
  • China
  • United States

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 Summary Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Acute Coronary Syndrome
  • Cardiology
  • World

The global platelet aggregation devices market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Cardiovascular Disease
  • Chronic Disease
  • Healthcare
  • Antiplatelet
  • Acute Coronary Syndrome
  • Stroke
  • Diagnostic Imaging
  • Heart Attack
  • Pain Relief
  • Point Of Care Testing
  • World

Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA, develops protein biomarkers to serve as the basis for novel diagnostic tests that require diagnosis and risk assessment.The company offers biomarker products such as nephro check test, a single use cartridge to detect biomarkers of acute kidney...

  • Diagnostics
  • Acute Coronary Syndrome
  • Clinical Trial
  • World
  • Medical Devices Sales

The ongoing clinical trial research report- “2019 Acute Coronary Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Acute Coronary Syndrome trials across the world. The report presents top level analysis of global Acute Coronary Syndrome clinical trials across countries, companies and universities. It is designed...

  • Acute Coronary Syndrome
  • Clinical Trial
  • World
  • APAC

This study covers the world outlook for Acute Coronary Syndrome (ACS) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the...

  • Acute Coronary Syndrome
  • World
  • Gross Domestic Product
  • Disposable Income

The North America Cardiac Biomarkers Testing Market would witness market growth of 10.7% CAGR during the forecast period (2019–2025). Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac...

  • Cardiovascular Disease
  • Biomarker
  • Heart Attack
  • Acute Coronary Syndrome
  • Point Of Care Testing
  • North America
  • Cardiovascular Disease Prevalence

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Acute Coronary Syndrome Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Acute Coronary Syndrome pipeline products. The Acute Coronary Syndrome pipeline guide presents complete overview of drugs...

  • Acute Coronary Syndrome
  • World

Worldwide, an estimated 2 to 3 million people are hospitalized due to ACS annually. The acute coronary syndrome is a common complication of coronary heart disease. ACS refers to a broad range of diseases including Unstable angina, Non-ST segment elevation MI, ST-segment elevation MI. A sudden decrease in blood flow into the heart is observed,...

  • Acute Coronary Syndrome
  • Angina
  • Coronary Heart Disease
  • Therapy
  • World

Acute Coronary Syndrome ongoing clinical trials report provides comprehensive analysis and trends in global Acute Coronary Syndrome disease clinical trials. The research work analyzes the ongoing Acute Coronary Syndrome clinical trial trends across countries and companies. The report focuses on drugs and therapies being evaluated for...

  • Acute Coronary Syndrome
  • Clinical Trial
  • World

Acute Coronary Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Acute Coronary Syndrome – Pipeline Review, H2 2016, provides an overview of the Acute Coronary Syndrome (Cardiovascular) pipeline landscape. Acute coronary syndrome is...

  • Acute Coronary Syndrome
  • World
  • Japan
  • Cause-Specific Mortality Rate
  • Hospital Occupancy Rate

About Anticoagulant Market Anticoagulant prevent clot formations or the enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists; DTIs; and factor Xa inhibitors are among the anticoagulant that are available in the market....

  • Drug Development
  • Cardiology
  • Surgery
  • Acute Coronary Syndrome
  • Marketing Research
  • United States
  • World
  • APAC
  • Drug Approval
  • Number Of Enterprises

Acute Coronary Syndrome - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H1 2016’, provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Coronary...

  • Acute Coronary Syndrome
  • World
  • Japan
  • Hospital Discharge
  • Cause-Specific Mortality Rate

The $1.9bn acute coronary syndrome (ACS) market will experience moderate growth over the forecast period, driven by uptake of Brilinta and Xarelto in the secondary-prevention setting. This report addresses the following questions: - How will the updated 2016 treatment guidelines impact the use of new antiplatelet agents...

  • Acute Coronary Syndrome
  • United States
  • Japan
  • European Union
  • Smoking Prevalence
  • Infectious Disease Mortality

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Coronary artery disease (CAD), which precipitates acute coronary syndrome (ACS), is the most common type of cardiovascular disease (CVD) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)....

  • Hospital
  • Therapy
  • Statins
  • Cardiovascular Drug
  • Acute Coronary Syndrome
  • ACE Inhibitor
  • World
  • Hospital Occupancy Rate
  • Infectious Disease Mortality